Skip to main content
NCBI home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1994 Feb;51(2):125–129. doi: 10.1136/oem.51.2.125

Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead.

K S Chia 1, A Mutti 1, C Tan 1, H Y Ong 1, J Jeyaratnam 1, C N Ong 1, E Lee 1
PMCID: PMC1127917  PMID: 8111460

Abstract

Urinary N-acetyl-beta-D-glucosaminidase (NAG) had been shown to be a useful early marker of renal injury. In workers exposed to lead it seems to be the only early marker but the dose response and dose effect relations are weak. Furthermore, the significance and underlying mechanism of increased urinary NAG activity is far from clear. By studying the isoenzyme profiles of urinary NAG, the significance and underlying mechanism may be further clarified. The heat labile (NAG-A) and heat stable (NAG-B) isoenzyme profiles of 128 workers exposed to lead from a lead stabiliser factory were analysed. NAG activity was expressed as total NAG, NAG-A, and NAG-B activity as well as ratios (NAG-B/total NAG and NAG-B/NAG-A). Exposure indices included the recent concentration of blood lead (BPb), a cumulative blood lead index (TBPb), and the recent change in concentration of blood lead (CBPb). The NAG indices correlated best with CBPb. Nearly 50% of the variation in NAG-B activity could be explained by the combination of all three exposure indices but only the CBPb was highly significant. When these exposure indices were entered separately into the regression equation, CBPb accounted for 36.3% of the variation in NAG-B activity, 5.7% was accounted for by TBPb and 2.7% by BPb. There was also no dose-effect or dose-response relation between the NAG variables and BPb or TBPb groups. With CBPb, there were dose-effect and dose-response relations. With CBPb, there was an increase in NAG variables in the group with more than 25% increase in blood lead over the past six months. The increase in NAG activity in this study is likely to be due to a recent increase in concentration of blood lead and hence presumably a recent rise in renal burden of inorganic lead. This suggests that the increase in urinary NAG activity is a form of acute response to a sharp increase in renal burden of lead, rather than to a cumulative dose. Heat stable NAG is part of the lysosomal membrane and is present in the urine when there is breakdown of lysosomes. Our data therefore contradict suggestions that the increase in urinary NAG activity is due to exocytosis.

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard A., Lauwerys R. Cadmium, NAG activity, and beta 2-microglobulin in the urine of cadmium pigment workers. Br J Ind Med. 1989 Sep;46(9):679–680. doi: 10.1136/oem.46.9.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernard A., Lauwerys R. Epidemiological application of early markers of nephrotoxicity. Toxicol Lett. 1989 Mar;46(1-3):293–306. doi: 10.1016/0378-4274(89)90137-9. [DOI] [PubMed] [Google Scholar]
  3. Chia K. S., Ong C. N., Ong H. Y., Endo G. Renal tubular function of workers exposed to low levels of cadmium. Br J Ind Med. 1989 Mar;46(3):165–170. doi: 10.1136/oem.46.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coratelli P., Giannattasio M., Lomonte C., Marzolla R., Rana F., L'Abbate N. Enzymuria to detect tubular injury in workers exposed to lead: a 12-month follow-up. Contrib Nephrol. 1988;68:207–211. doi: 10.1159/000416515. [DOI] [PubMed] [Google Scholar]
  5. Dance N., Price R. G., Cattell W. R., Lansdell J., Richards B. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease. Clin Chim Acta. 1970 Jan;27(1):87–92. doi: 10.1016/0009-8981(70)90378-5. [DOI] [PubMed] [Google Scholar]
  6. Dance N., Price R. G., Robinson D., Stirling J. L. Beta-galactosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase in human kidney. Clin Chim Acta. 1969 May;24(2):189–197. doi: 10.1016/0009-8981(69)90311-8. [DOI] [PubMed] [Google Scholar]
  7. Ellis B. G., Tucker S. M., Thompson A. E., Price R. G. Presence of serum and tissue forms of N-acetyl-beta-glucosaminidase in urine from patients with renal disease. Clin Chim Acta. 1975 Oct 15;64(2):195–202. doi: 10.1016/0009-8981(75)90201-6. [DOI] [PubMed] [Google Scholar]
  8. Gerhardsson L., Chettle D. R., Englyst V., Nordberg G. F., Nyhlin H., Scott M. C., Todd A. C., Vesterberg O. Kidney effects in long term exposed lead smelter workers. Br J Ind Med. 1992 Mar;49(3):186–192. doi: 10.1136/oem.49.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibey R., Dupond J. L., Henry J. C. Urinary N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins. Clin Chim Acta. 1984 Feb 14;137(1):1–11. doi: 10.1016/0009-8981(84)90306-1. [DOI] [PubMed] [Google Scholar]
  10. Goyer R. A. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett. 1989 Mar;46(1-3):153–162. doi: 10.1016/0378-4274(89)90124-0. [DOI] [PubMed] [Google Scholar]
  11. Landrigan P. J. Toxicity of lead at low dose. Br J Ind Med. 1989 Sep;46(9):593–596. doi: 10.1136/oem.46.9.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lockwood T. D., Bosmann H. B. The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol Appl Pharmacol. 1979 Jun 30;49(2):323–336. doi: 10.1016/0041-008x(79)90257-6. [DOI] [PubMed] [Google Scholar]
  13. Meyer B. R., Fischbein A., Rosenman K., Lerman Y., Drayer D. E., Reidenberg M. M. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med. 1984 Jun;76(6):989–998. doi: 10.1016/0002-9343(84)90847-7. [DOI] [PubMed] [Google Scholar]
  14. Noto A., Ogawa Y., Mori S., Yoshioka M., Kitakaze T., Hori T., Nakamura M., Miyake T. Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem. 1983 Oct;29(10):1713–1716. [PubMed] [Google Scholar]
  15. Price R. G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology. 1982;23(2-3):99–134. doi: 10.1016/0300-483x(82)90092-0. [DOI] [PubMed] [Google Scholar]
  16. Thornley C., Dawnay A., Cattell W. R. Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond) 1985 May;68(5):529–535. doi: 10.1042/cs0680529. [DOI] [PubMed] [Google Scholar]
  17. Verschoor M., Wibowo A., Herber R., van Hemmen J., Zielhuis R. Influence of occupational low-level lead exposure on renal parameters. Am J Ind Med. 1987;12(4):341–351. doi: 10.1002/ajim.4700120402. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES